Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 8.34 USD -5.55% Market Closed
Market Cap: 304.6m USD
Have any thoughts about
Iteos Therapeutics Inc?
Write Note

Iteos Therapeutics Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iteos Therapeutics Inc
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Iteos Therapeutics Inc
NASDAQ:ITOS
Net Income (Common)
-$112.6m
CAGR 3-Years
-37%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$126m
CAGR 3-Years
-74%
CAGR 5-Years
-46%
CAGR 10-Years
-35%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$479.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is Iteos Therapeutics Inc's Net Income (Common)?
Net Income (Common)
-112.6m USD

Based on the financial report for Dec 31, 2023, Iteos Therapeutics Inc's Net Income (Common) amounts to -112.6m USD.

What is Iteos Therapeutics Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-41%

The average annual Net Income (Common) growth rates for Iteos Therapeutics Inc have been -37% over the past three years , -41% over the past five years .

Back to Top